Navigation Links
Enteris BioPharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics
Date:8/5/2013

BOONTON, N.J., Aug. 5, 2013 /PRNewswire/ -- Enteris BioPharma, Inc., an industry leader in innovative oral dosage formulations, today announced the official launch of its business, operational and development activities as the Company unveils enhancements to its clinically proven oral peptide delivery platform, Peptelligence™, that extend the technology to small molecule therapeutics.  Enteris recently acquired the Peptelligence™ platform, along with proven nasal delivery technology and a recombinant manufacturing process for therapeutically relevant peptides, from Unigene Laboratories, Inc.

In conjunction with the launch of the company and its expansion to oral delivery of small molecules, Enteris has appointed Brian Zietsman as President and Chief Financial Officer, Nozer Mehta, Ph.D., as Chief Scientific Officer and Paul Shields, Ph.D., as its Vice President of Operations.
Mr. Zietsman, Dr. Mehta and Dr. Shields will spearhead Enteris' mission of developing and delivering innovative formulation solutions for peptides and small molecules that leverage the Company's breakthrough delivery platform technologies including Peptelligence™. 

Mr. Zietsman commented, "I greatly welcome the opportunity to lead Enteris BioPharma as we seek to become the industry leader in the oral delivery of peptides and difficult to deliver small molecule therapeutics.  As a company, we are focused on solving challenging formulation issues for our partners using our proprietary, clinically-proven Peptelligence™ technology in combination with our formulation development and manufacturing expertise.  In doing so, we are targeting the myriad therapeutic indications in which physician acceptance and patient compliance can be improved through more convenient and effective medications."

Peptelligence&#
'/>"/>

SOURCE Enteris BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes
3. CeNeRx BioPharma Completes $4.85 Million Financing
4. PDL BioPharma Completes Regular Quarterly Dividend Payment
5. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
6. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
7. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
8. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
9. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
10. Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
11. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... IL (PRWEB) February 26, 2015 Already ... its gauging line by expanding its Length Gauge offerings ... ACANTO gauges. , Specifically, HEIDENHAIN’s pencil probe-style ... improved force specification. Two new 1Vpp, 12mm stroke ... lower force applications. One is a variant with a ...
(Date:2/26/2015)... February 26, 2015 According to a ... Biotechnology Market For Transgenic Crops (Corn, Soybean, Cotton and ... Analysis, Size, Share, Growth, Trends and Forecast, 2013 – ... 15,300 million in 2012 and is expected to reach ... of 9.5% from 2013 to 2019. , Demand ...
(Date:2/26/2015)... Feb. 26, 2015 Ceres, Inc . ... in Oracle PartnerNetwork. In attaining Gold Level membership, Ceres ... establish Oracle-related knowledge in delivering Ceres, Persephone genome visualization ... customers. Originally developed for in-house use by ... in and out of massive amounts of genetic data, ...
(Date:2/26/2015)... WOODLANDS, Texas , Feb. 26, 2015   Lexicon ... that Lexicon management will present at the Cowen 35 th ... at 8:40 a.m. EST in Boston . ... programs and milestones. A webcast of the presentation ... An archived version of the presentation will be available at ...
Breaking Biology Technology:Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3Ceres Becomes Oracle PartnerNetwork Gold Level Partner 2Ceres Becomes Oracle PartnerNetwork Gold Level Partner 3Ceres Becomes Oracle PartnerNetwork Gold Level Partner 4Lexicon To Present At The Cowen 35th Annual Health Care Conference 2
... ... of Energy (DOE) bio-energy research centers, has selected Surety’s AbsoluteProof trusted time-stamping service to ... ... the leading provider of data integrity protection solutions , today announced that the ...
... , WILMINGTON, Del. ... AZN ) and the University of Virginia (UVa) ... a strategic research collaboration to enhance development of new ... secondary focus on peripheral vascular disease (PAD). , (Logo: ...
... , , BRIARCLIFF MANOR, N.Y., Dec. ... of the International Society for Medical Publication Professionals (ISMPP) will ... UK. More than 100 attendees are expected at this prestigious ... medical writers and medical agencies to discuss the changing world ...
Cached Biology Technology:Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2
(Date:2/9/2015)... -- Lintec of America recently announced an exclusive license to ... including sheets, yarns and ribbons, developed at the University ... vast industrial resources of the global Lintec Group, headquartered ... America is forming the Nano-Science and Technology Center (NSTC) ... scaling up the manufacturing and commercialization of nano engineered ...
(Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
(Date:2/5/2015)... 26, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... http://www.nxt-id.com/ ) as part of its 2015 marketing and ... launched its new consumer website for Wocketwallet.com earlier this ... of NXT-ID said, "Our new corporate website naturally showcases ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... 31, 2010) -- A new imaging system using six ... (ocular fundus) may pave the way for doctors to ... such as age-related macular degeneration and diabetic retinopathy. The ... Scientific Instruments, which is published by the American ...
... Barbara, Calif.) Two new groundbreaking scientific papers by ... nanosize biological particles with the potential to fight cancer ... are considered "green" nanobiotechnology because they use no artificial ... biochemistry at UCSB, explained that there is nothing short ...
... created the first two-terminal memory chips that use only ... planet, in a way that should be easily adaptable ... limits of miniaturization subject to Moore,s Law. ... James Tour showed how electrical current could repeatedly break ...
Cached Biology News:LEDs illuminate eye for ocular disease screening 2Developments in nanobiotechnology at UCSB point to medical applications 2Silicon oxide circuits break barrier 2Silicon oxide circuits break barrier 3Silicon oxide circuits break barrier 4